Tag Archive for: Innovation

Neuraxpharm reports another year of sustained growth and international expansion

/in

CNS specialist continues growth strategy across Europe and beyond, optimizing commercial efficiency and maintaining strong focus on innovation Barcelona, Spain and Düsseldorf, Germany – 14 November 2024 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its rebranding as Neuraxpharm […]

Read more

Lonza’s Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC

/in

Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza’s commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat’s artificial intelligence (AI)/machine learning (ML)-powered antibody design platform, Milliner™ was used to design a highly differentiated […]

Read more

AMSilk joins World Economic Forum’s Global Innovators Community

/in

Neuried, Germany, 03 September 2024: AMSilk GmbH (“AMSilk”), a global leader in advanced biomaterials made from spider silk-based proteins, today announces it has been invited to join the World Economic Forum’s Global Innovators Community. The Global Innovators Community, an invite-only initiative, was established in 2019 to bring together companies making strides to innovate and contribute […]

Read more

Research published in Journal of the American Chemical Society highlights potential of HIF Inhibition as a therapeutic approach for cancers

/in

Research led by Curve CSO Professor Ali Tavassoli’s laboratory at University of Southampton Landmark paper on dual HIF-1 and HIF-2 inhibitor that works by inhibiting the interaction of both HIF-1α and HIF-2α with HIF-1β   Southampton, UK, 26 March 2024 – Curve Therapeutics (“Curve” or the “Company”), a private biotechnology company pioneering a revolutionary intracellular […]

Read more

2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update

/in

Established the Novo Holdings Bioindustrial Investments team, now overseeing a dynamic portfolio of 23 companies. Made substantial investments, solidifying Novo Holdings’ position as one of the world’s foremost active investors in the bioindustrial sector. Welcomed three innovative companies to our portfolio. Achieved significant milestones with existing portfolio companies, showcasing strong progress and commitment to sustainable […]

Read more